In March 2025, the company introduced new strategies for just a direct-to-buyer presenting of its Wegovy weight loss drug. The company set up a whole new pharmacy, called NovoCare, which would demand buyers $499 per 30 days for use of the drug, a lot less than 50 percent the expense of the drug